DK3412664T3 - Heterocyklisk sulfonamidderivat og medicin indeholdende samme - Google Patents
Heterocyklisk sulfonamidderivat og medicin indeholdende samme Download PDFInfo
- Publication number
- DK3412664T3 DK3412664T3 DK17747613.2T DK17747613T DK3412664T3 DK 3412664 T3 DK3412664 T3 DK 3412664T3 DK 17747613 T DK17747613 T DK 17747613T DK 3412664 T3 DK3412664 T3 DK 3412664T3
- Authority
- DK
- Denmark
- Prior art keywords
- sulfonide
- heterocyclic
- derivative
- same
- medicine containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016021358 | 2016-02-05 | ||
| PCT/JP2017/004134 WO2017135462A1 (ja) | 2016-02-05 | 2017-02-03 | 複素環スルホンアミド誘導体及びそれを含有する医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3412664T3 true DK3412664T3 (da) | 2022-06-07 |
Family
ID=59499709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17747613.2T DK3412664T3 (da) | 2016-02-05 | 2017-02-03 | Heterocyklisk sulfonamidderivat og medicin indeholdende samme |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10584116B2 (da) |
| EP (1) | EP3412664B1 (da) |
| JP (1) | JP6906449B2 (da) |
| KR (1) | KR20180104150A (da) |
| CN (1) | CN108602807B (da) |
| AU (1) | AU2017213993B2 (da) |
| BR (1) | BR112018015851A2 (da) |
| CA (1) | CA3012812A1 (da) |
| DK (1) | DK3412664T3 (da) |
| EA (1) | EA037264B1 (da) |
| ES (1) | ES2911416T3 (da) |
| MA (1) | MA43978A (da) |
| MX (1) | MX2018009458A (da) |
| PL (1) | PL3412664T3 (da) |
| WO (1) | WO2017135462A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3487853B1 (en) * | 2016-07-20 | 2022-06-08 | F. Hoffmann-La Roche AG | Bicyclic proline compounds |
| FR3114235A1 (fr) | 2020-09-18 | 2022-03-25 | Université Grenoble Alpes | Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer |
| IT202100015098A1 (it) | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
| WO2023033097A1 (ja) * | 2021-09-02 | 2023-03-09 | Ｅａファーマ株式会社 | 複素環スルホンアミド誘導体の製造方法、およびその合成中間体 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017612B2 (en) * | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| US8614201B2 (en) | 2009-06-05 | 2013-12-24 | Janssen Pharmaceutica Nv | Heterocyclic amides as modulators of TRPA1 |
| EP2520566A1 (en) * | 2011-05-06 | 2012-11-07 | Orion Corporation | New Pharmaceutical Compounds |
| EP2805718B1 (en) | 2012-01-17 | 2018-04-04 | EA Pharma Co., Ltd. | Heterocyclic amide derivative and pharmaceutical product containing same |
| WO2014049047A1 (en) | 2012-09-27 | 2014-04-03 | F. Hoffmann-La Roche Ag | Substituted sulfonamide compounds |
| CN104854086B (zh) * | 2012-12-18 | 2017-06-27 | Ea制药株式会社 | 杂环酰胺衍生物和含有其的药物 |
| EP2774919A1 (en) | 2013-03-06 | 2014-09-10 | Pharmeste S.R.L. In Liquidazione | Novel sulfonamide TRPA1 receptor antagonists |
| BR112016002012A2 (pt) * | 2013-10-11 | 2017-08-01 | Hoffmann La Roche | compostos de sulfonamida heterocíclica substituída úteis como moduladores de trpa1 |
| MX2016009794A (es) * | 2014-01-28 | 2017-01-13 | Ea Pharma Co Ltd | Derivado de sulfonamida heterociclico y medicina que comprende el mismo. |
| SG11201706451TA (en) * | 2015-02-15 | 2017-09-28 | Hoffmann La Roche | 1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as trpa1 antagonists |
| CN107849029A (zh) | 2015-07-29 | 2018-03-27 | Ea制药株式会社 | 环丙烷衍生物及含有其的药物 |
-
2017
- 2017-02-03 EP EP17747613.2A patent/EP3412664B1/en active Active
- 2017-02-03 PL PL17747613T patent/PL3412664T3/pl unknown
- 2017-02-03 MX MX2018009458A patent/MX2018009458A/es unknown
- 2017-02-03 CN CN201780009998.3A patent/CN108602807B/zh active Active
- 2017-02-03 KR KR1020187025206A patent/KR20180104150A/ko not_active Application Discontinuation
- 2017-02-03 JP JP2017565677A patent/JP6906449B2/ja active Active
- 2017-02-03 EA EA201891782A patent/EA037264B1/ru unknown
- 2017-02-03 BR BR112018015851-8A patent/BR112018015851A2/pt active Search and Examination
- 2017-02-03 AU AU2017213993A patent/AU2017213993B2/en active Active
- 2017-02-03 CA CA3012812A patent/CA3012812A1/en active Pending
- 2017-02-03 WO PCT/JP2017/004134 patent/WO2017135462A1/ja active Application Filing
- 2017-02-03 MA MA043978A patent/MA43978A/fr unknown
- 2017-02-03 ES ES17747613T patent/ES2911416T3/es active Active
- 2017-02-03 DK DK17747613.2T patent/DK3412664T3/da active
-
2018
- 2018-08-03 US US16/054,077 patent/US10584116B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017213993B2 (en) | 2021-03-25 |
| KR20180104150A (ko) | 2018-09-19 |
| US20190023699A1 (en) | 2019-01-24 |
| EA037264B1 (ru) | 2021-03-01 |
| EP3412664A1 (en) | 2018-12-12 |
| JPWO2017135462A1 (ja) | 2018-12-13 |
| EA201891782A1 (ru) | 2019-06-28 |
| AU2017213993A1 (en) | 2018-09-13 |
| PL3412664T3 (pl) | 2022-06-06 |
| ES2911416T3 (es) | 2022-05-19 |
| EP3412664A4 (en) | 2019-10-16 |
| JP6906449B2 (ja) | 2021-07-21 |
| MA43978A (fr) | 2018-12-12 |
| CN108602807A (zh) | 2018-09-28 |
| WO2017135462A1 (ja) | 2017-08-10 |
| MX2018009458A (es) | 2018-09-21 |
| EP3412664B1 (en) | 2022-03-30 |
| US10584116B2 (en) | 2020-03-10 |
| CN108602807B (zh) | 2022-05-13 |
| CA3012812A1 (en) | 2017-08-10 |
| BR112018015851A2 (pt) | 2018-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3565550T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan | |
| DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
| DK3478693T3 (da) | Boronsyrederivater og terapeutiske anvendelser deraf | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| DK3310371T3 (da) | Glucagon og GLP-1-Co-agonistforbindelser | |
| DK3505519T3 (da) | Pyridinamin-substituerede heterotricyclo-forbindelser, fremstilling deraf og anvendelse i medicin | |
| DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| DK3345587T3 (da) | Beholderholdeelement og medicinsk beholdersæt | |
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| DK3102200T3 (da) | Terapeutisk forbindelse og sammensætning | |
| DK3514153T3 (da) | Pyrimidinforbindelse og farmaceutisk anvendelse deraf | |
| DK3263565T3 (da) | Cyklisk aminderivat og farmaceutisk anvendelse deraf | |
| PL3287443T3 (pl) | 6-członowa pochodna heterocykliczna i kompozycja farmaceutyczna ją zawierająca | |
| DK3103715T3 (da) | Styreindretning og styringsfremgangsmåde dertil | |
| DK3409660T3 (da) | Cyklisk aminderivat og farmaceutisk anvendelse deraf | |
| DK3236991T3 (da) | Fgf21-derivater og anvendelser deraf | |
| DK3204085T3 (da) | Hus og lægemiddeladministrationsanordning hermed | |
| DK3231793T3 (da) | Dihydropyromidin-2-on-forbindelser og medicinske anvendelser deraf | |
| HK1232222A1 (zh) | 芳雜環類衍生物及其在藥物上的應用 | |
| DK3672948T3 (da) | Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser | |
| DK3412664T3 (da) | Heterocyklisk sulfonamidderivat og medicin indeholdende samme | |
| DK3386956T3 (da) | Fumagillolderivater og polymorfer deraf | |
| DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf |